OrthoPediatrics (NASDAQ:KIDS) Releases Earnings Results, Beats Estimates By $0.04 EPS

OrthoPediatrics (NASDAQ:KIDS) issued its earnings results on Tuesday. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04, Zacks reports. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. The firm had revenue of $52.67 million for the quarter, compared to the consensus estimate of $51.16 million. During the same quarter in the previous year, the company posted ($0.23) earnings per share. OrthoPediatrics updated its FY 2025 guidance to EPS.

OrthoPediatrics Stock Performance

NASDAQ:KIDS opened at $22.89 on Wednesday. The firm has a 50-day moving average price of $24.39 and a 200 day moving average price of $25.94. OrthoPediatrics has a 12-month low of $21.02 and a 12-month high of $35.99. The firm has a market capitalization of $554.30 million, a PE ratio of -18.61 and a beta of 1.14. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Needham & Company LLC reissued a “buy” rating and issued a $42.00 price target on shares of OrthoPediatrics in a research note on Wednesday. Truist Financial decreased their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.